Propylthiouracil inhibits the conversion of L-thyroxine to L-triiodothyronine. An explanation of the antithyroxine effect of propylthiouracil and evidence supporting the concept that triiodothyronine is the active thyroid hormone.
6-n-propylthiouracil (PTU) administered to male Sprague-Dawley rats maintained on 2 and 5 mug L-thyroxine (T(4))/100 g body weight resulted in a marked reduction in the rate of conversion of L-thyroxine to L-triiodothyronine (T(3)). These effects could not be ascribed to induced hypothyroidism since the group maintained on 5 mug T(4)/day had normal levels of liver mitochondrial alpha glycerophosphate dehydrogenase. In confirmation of previous studies, PTU also reduced the fractional rate of deiodination of T(3). These observations provide a possible explanation of the many published observations indicating that PTU antagonizes the tissue effects of T(4) but not of T(3). The data suggest that monodeiodination of T(4) but not of T(3) is essential before hormonal effects can be manifested at the cellular level.
D000284:Administration, Oral; D000818:Animals; D002854:Chromatography, Paper; D002855:Chromatography, Thin Layer; D005954:Glucosephosphate Dehydrogenase / Q000032:analysis; D007279:Injections, Subcutaneous; D007457:Iodine Radioisotopes; D008297:Male; D008930:Mitochondria, Liver / Q000201:enzymology; D011441:Propylthiouracil / Q000008:administration & dosage / Q000494:pharmacology*; D051381:Rats; D013965:Thyroidectomy; D013974:Thyroxine / Q000008:administration & dosage / Q000037:antagonists & inhibitors / Q000378:metabolism*; D014284:Triiodothyronine / Q000302:isolation & purification / Q000378:metabolism*
D007457:Iodine Radioisotopes; D014284:Triiodothyronine; D011441:Propylthiouracil; D005954:Glucosephosphate Dehydrogenase; D013974:Thyroxine